Why Long-Term Smokers May Have a Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria.
Category: Lung Cancer
Lung Cancer
Latest
Lung Cancer
Latest
Lucence Announces Medicare Reimbursement Decision for Lung Cancer Assay
Lucence announced that Palmetto GBA finalized a foundational local coverage determination (LCD) for the LiquidHALLMARKassay.
Lung Cancer
Latest
Lung Cancer Screening Improves Stage I Detection, Reduces Stage IV Cases
Implementing lung cancer screening at four diverse healthcare systems resulted in a 6.6% decrease in Stage IV disease.
CorePath Partners with Cizzle Biotech to Develop Early Lung Cancer Detection Test
CorePath is partnering with Cizzle Biotechnology to develop and offer a proprietary early-stage lung cancer blood test for the U.S.
Read More
Researchers Develop a Novel AI Algorithm for Digital Pathology Analysis
Researchers developed a novel AI algorithm to classify lung cancer subtype based on lung tissue images from resected tumors.
Read More
Researchers Develop Model to Detect & Combat Lung Cancer Recurrence
Researchers found a process to study the actions of circulating tumor cells responsible for cancer recurrence of non-small cell lung cancer.
Read More
Blood Test Helps Identify Who Needs Lung Cancer Assessment
A blood test in tandem with reviewing an individual’s smoking history can more accurately determine if they may benefit from lung cancer screening.
Read More
Blood Drops May Help Detect Early-Stage Lung Cancer
A study shows proof-of-concept of using a drop of blood to reveal lung cancer, which may help diagnose early-stage lung cancer in asymptomatic patients.
Read More
FDA Approves Thermo Fisher’s Test to Identify Therapies for Non-Small Cell Lung Cancer Patients
Thermo Fisher’s companion diagnostic test to identify targeted therapies for non-small cell lung cancer patients was granted premarket approval by the FDA.
Read More
Quest Diagnostics Offers New Liquid Biopsy Lung Cancer Test
Biocept’s liquid biopsy-based Target Selector NGS Lung Panel test aids genomic profiling in patients with advanced non-small cell lung cancer (NSCLC).
Read More
NIH Awards $2.4 Million Research Grant for Better Lung Nodule Diagnosis
An engineering professor has received a $2.4M grant for a faster, less painful way to diagnose malignant solitary pulmonary nodules.
Read More
Nasal Swab Test Can Improve Early Lung Cancer Assessment
Data supports that a noninvasive nasal swab test can help physicians more accurately assess lung cancer risk in patients with lung nodules.
Read More
OneOncology: NGS Testing Is Backbone of Personalized Treatments
OneOncology and Genentech presented data at a symposium that examined genomic profiling and biomarker testing patterns in community oncology centers.
Read More
Thermo Fisher’s Oncomine Dx Receives FDA Premarket Approval
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic.
Read More
Community Oncologists Use Biomarker Testing Less Than Academic Clinicians
A recent report showed less than half of community oncologists used biomarker testing for lung cancer — compared to 73% of academic clinicians.
Read More
AI Blood Test Can ID Lung Cancers with High Accuracy
Researchers have developed novel artificial intelligence blood testing technology that detected over 90% of lung cancers from 800 samples.
Read More
New Liquid Biopsy for Lung Cancer Has High Detection Rate
Delfi Diagnostics’s lung cancer screening technology, which analyzes genome-wide cell-free DNA fragmentation profiles, detected 90% of cases.
Read More
Validation Study: Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
The new findings show the Percepta Nasal Swab, a first-of-its-kind genomic test, accurately classifies lung cancer risk in current or former smokers with lung nodules so that those with benign nodules may safely avoid unnecessary additional procedures.
Read More